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Abstract
Background: It has been speculated that the biostimulatory effect of Low Level Laser Therapy
could cause undesirable enhancement of tumor growth in neoplastic diseases. The aim of the
present study is to analyze the behavior of melanoma cells (B16F10) in vitro and the in vivo
development of melanoma in mice after laser irradiation.
Methods: We performed a controlled in vitro study on B16F10 melanoma cells to investigate cell
viability and cell cycle changes by the Tripan Blue, MTT and cell quest histogram tests at 24, 48 and
72 h post irradiation. The in vivo mouse model (male Balb C, n = 21) of melanoma was used to
analyze tumor volume and histological characteristics. Laser irradiation was performed three times
(once a day for three consecutive days) with a 660 nm 50 mW CW laser, beam spot size 2 mm2,
irradiance 2.5 W/cm2 and irradiation times of 60s (dose 150 J/cm2) and 420s (dose 1050 J/cm2)
respectively.
Results: There were no statistically significant differences between the in vitro groups, except for
an increase in the hypodiploid melanoma cells (8.48 ± 1.40% and 4.26 ± 0.60%) at 72 h post-
irradiation. This cancer-protective effect was not reproduced in the in vivo experiment where
outcome measures for the 150 J/cm2 dose group were not significantly different from controls. For
the 1050 J/cm2 dose group, there were significant increases in tumor volume, blood vessels and cell
abnormalities compared to the other groups.
Conclusion: LLLT Irradiation should be avoided over melanomas as the combination of high
irradiance (2.5 W/cm2) and high dose (1050 J/cm2) significantly increases melanoma tumor growth
in vivo.
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Background
Malignant melanoma represents a burden to modern soci-
ety and requires considerable efforts in terms of health
service utilization. The incidence is increasing worldwide
and in the Netherlands the prevalence is currently 16.1/
100,000 with a mortality rate of 3.0/100,000[1].
Low level laser therapy (LLLT) has gained increasing pop-
ularity as a treatment for soft tissue injuries and joint con-
ditions. It is applied transcutaneously with typical
irradiances being 10 mW/cm2 - 5,000 mW/cm2, treat-
ments times being in the range of 10 seconds - 2 minutes,
with total energy delivered of 1 - 4 Joules(J)/cm2 per point
when targeting joints, tendons and muscles. The cellular
proliferative potential of LLLT irradiation has attracted
some negative speculation that this could also increase
tumor growth in neoplasic diseases. Previous studies of
LLLT irradiation of tumor cells in vitro have generated
conflicting research data across a range of cultivated
tumor cell lines and irradiation parameters [2-11] but
there have been relatively few in vivo studies published
[12,13]. In vivo studies are essential for the study of disease
development and should be the main tool for studying
the behavior of tumor cells. The complexity of the multi-
cellular environment in an ongoing disease makes it hard
to predict tumor behavior and cell culture studies alone
are inadequate to for assessment of tumor responses.
Increases in cell proliferation and collagen biosynthesis
after LLLT in wound healing improvement has already
been observed in the pioneer work of Mester et al. [14].
The following decades were marked by a large quantity of
research articles in LLLT. A better understanding of laser
light modulatory mechanisms was obtained, but this
effort also yielded conflicting results. There is a shortage of
evidence about the effects of LLLT in malignant condi-
tions such as melanoma. The complete biochemical
mechanisms of cell proliferation after LLLT irradiation are
still uncertain and we believe there is a need to study the
effects of LLLT on tumor growth in suitable cell and ani-
mal models.
The aim of the present work is to study the effect of LLLT
irradiation both in vitro and in vivo. For this purpose we
decided to study cell viability and cell cycle changes in
melanoma cells (B16F10) in vitro, and their behavior
when injected subcutaneously into Balb C mice in vivo.
Methods
All the experimental procedures were submitted to and
approved by the Ethical Committee at the Cruzeiro do Sul
University.
Cell culture
B16F10 murine melanoma cells were obtained from
ATCC (clone CRL 6457). Melanoma cells were grown in
RPMI 1640 medium supplemented with 10% fetal bovine
serum (FBS), 100 U/mL penicillin/streptomycin and 24
mM NaHCO3 at 37°C in a humidified atmosphere con-
taining 5% CO2. Cells were seeded at an initial density of
2 × 104 cells/cm2 (B16F10) for cell viability, which was
determined by the MTT method and 1 × 106 cells/cm2 for
the Trypan blue exclusion test.
In vitro laser irradiation
B16F10 cells were irradiated a total of three times (once a
day for three consecutive days) in a 96 well culture plate
for the MTT method and in a 12 well plate for Trypan blue
and cytometric assays. Irradiation was performed with a
660 nm, 50 mW Continuous Wave (CW) laser, beam spot
size 2 mm2, irradiance 2.5 W/cm2 (Quasar Medical - Den-
toflex, São Paulo, Brasil). The seeded wells were spaced 5
cm apart in all directions and a thin aluminum sheet was
placed halfway (2.5 cm) between them to prevent unin-
tentional light scattering between the wells. The wells
were randomly divided into a control group which
received no irradiation, and a treatment group which
received an LLLT dose of 150 J/cm2 with an irradiance of
2.5 W/cm2 for 60 seconds (3J), while a second group
received sessions with an LLLT dose of 1050 J/cm2 with an
irradiance of 2.5 W/cm2 for 420 seconds (21J). Total
energy delivered after all three sessions was 9J and 63J
respectively in the irradiated groups. A support device
held the LLLT emission tip perpendicular to and 2 mm
distant from the culture media. Irradiation was carefully
timed and carried out in a dark laminar flux hood.
Animals
The animals were isogenic male Balb C mice (n = 21),
which were randomized into one of three groups; a con-
trol group (n = 7), a "low" dose group (n = 7) and a "high"
dose group (n = 7). The mice were injected subcutane-
ously with a suspension of 2 × 106 B16F10 melanoma
cells.
In vivo laser irradiation
After fifteen days of tumor growth the animals were irra-
diated three times (once a day for three consecutive days)
at the site of the injected melanoma cells with the same
laser and laser parameters as used in the in vitro study. Irra-
diation was performed with a 660 nm 660 nm, 50 mW
Continuous Wave (CW) laser, beam spot size 2 mm2, irra-
diance 2.5 W/cm2 (Quasar Medical - Dentoflex, São
Paulo, Brasil). Control Group: Received no irradiation
Group 1: Received three LLLT sessions (once a day for
three consecutive days) each of 60 seconds with a dose of
150 J/cm2, (energy delivered per session was 3J, total
energy delivered after three sessions was 9J) Group 2:
Received three sessions (once a day for three consecutive
days) each of 420 seconds with a dose of 1050 J/cm2,
(energy delivered per session was 21J, and total energy
delivered after three sessions was 63J).
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Outcome measures in vitro
Cell viability and cell changes were determined by MTT
method and Trypan blue exclusion tests (B16F10). Cells
were seeded at a density of 1 × 106 cells/Cm2 (B16F10). At
the end of the experiment, cells were treated with trypsin
(0.05% trypsin in 0.02% EDTA) and washed 3 times with
PBS, fixed in 70% ethanol, and stained with propidium
iodide (PI) 50 mg/10 uL final concentration, these can
distinguish hypodiploid (non-viable or dead cells) from
diploid (viable) cells, for 30 min in the dark. All analyses
were done using a FACScalibur flow cytometer (Becton
Dickinson, San Jose, CA). The red fluorescence of PI was
collected through a 585/42-nm band-pass filter, and the
fluorescence signals were measured in a linear scale of
1024 channels. For each sample, at least 10,000 events
were acquired and the data were analyzed using appropri-
ate software (CELLQuest, Becton Dickinson, San Jose,
CA). Cell viability was assessed by counting adherent and
non-adherent cells and measured by the cellular permea-
bility to propidium iodide. Cells in S/G2/M (proliferating)
and G0/G1 phases, and hypodiploid cells (cells under
death process) were analyzed.
Outcome measures in vivo
Tumor cell growth area was estimated measuring length
and width with a paquimeter device and using the for-
mula: volume = length × width2 π div 6. Histological
tumor analysis was performed after tumor volume meas-
urements. Animals were anaesthetized with inhaled
halothane and sacrificed by cervical dislocation. Tumor
mass was immediately removed and immersed in a 4%
phosphate buffered paraformaldehide solution for 48 h.
Specimens were dehydratated and embedded in paraffin
prior to the 5 μm microtome sections. Histological sec-
tions were collected on glass slides and hematoxylin-eosin
stained. Analysis and photographs were carried out in a
Nikon-YS100 photomicroscope.
Statistical analysis
The obtained data were first plotted for analysis of normal
distribution, and statistical analysis was then performed
with parametric tests if the data were normally distrib-
uted. The statistical level of significance was set at P < 0.05,
and significance was tested statistically by an ANOVA-test.
The mean values and its standard error (SE) were calcu-
lated, and differences between control group data and the
irradiated group data were tested statistically with Bonfer-
roni's test.
Results
In vitro experiments
The Trypan Blue dye exclusion test showed no statistical
differences in proliferation or cell death numbers among
irradiated groups and control group in the different times
analyzed (Figure 1).
The MTT colorimetric test showed no statistical differ-
ences in proliferation or cell death numbers among irradi-
ated groups and control group in the different times
analyzed (Figure 2).
Cell cycle analysis in B16F10 cells showed no statistically
significant differences in the cell numbers in G0/G1, S,
G2/M phases at 24 h, 48 h and 72 h among irradiated
groups and control group (Figure 3, 4, 5).
There was statistically a significant difference (p < 0.05) in
hypodiploid cells (possible cell death) at 72 h between
the irradiated and control groups (8.48 ± 1.40% and 4.26
± 0.60%). The increase in apoptosis was most prominent
in the low dose 150 J/cm2 group (Figure 6).
In vivo experiments
15 days after the B16F10 cell injections all the animals
presented average tumor mass volume of 0.12 ± 0.04 cm3.
The increase of the tumor mass volume of control and
irradiated groups are shown in Figure 7.
Total B16F10 cell count number by Trypan blue exclusion me hodFigure 1
Total B16F10 cell count number by Trypan blue 
exclusion method. No significant differences were 
observed.
Proliferative-inhibitory effects of low-level laser irradiation in B16F10 cells evaluated by MTT c lorimetric methoFigure 2
Proliferative-inhibitory effects of low-level laser irra-
diation in B16F10 cells evaluated by MTT colorimet-
ric method. * = p < 0.05.
BMC Cancer 2009, 9:404 http://www.biomedcentral.com/1471-2407/9/404
Page 4 of 8
(page number not for citation purposes)
At the 10th day, the tumor mass volume was significantly
higher in the 1050 J/cm2 group when compared to the 150
J/cm2 and the control group. No significant difference in
tumor volume was observed between the 150 J/cm2 and
the control group (Figure 8).
The macroscopic appearance of dissected tumor differed
between the 1050 J/cm2 group and the two other groups.
In addition to a marked increase of the volume of this
group, the connective tissue of the capsule appeared sticky
to the tumor mass and to the adjacent muscle tissue. A
greater number of blood vessels were also observed (Fig-
ure 9)
Histological sections of the control group revealed a dense
mass of melanin producing melanoma cells invaded by
lymphocytes, plasma cells and macrophages. A rich vascu-
lar bed filled with leukocytes and red blood cells can be
observed. Some restricted areas of necrotic tissue were also
present. In the connective tissue of the capsule, immuno-
logical cells spread through thin collagen fibers and
edema areas (Figure 10).
In the histological sections of the 150 J/cm2 group,
immune cells were less frequent in the tumor mass, and
large blood vessels were filled with leukocytes and red
blood cells. Necrotic areas were slightly larger compared
Cell-Quest acquisition histogram of B16F10 cell cycle phases after 24 h irradiat onFigure 3
Cell-Quest acquisition histogram of B16F10 cell cycle 
phases after 24 h irradiation. Red dot refers to control 
group; green line refers to 150 J/cm2 group and purple curve 
refers to 1050 J/cm2 group.
Cell-Quest acquisition histogram of B16F10 cell cycle phases after 48 h irradiat onFigure 4
Cell-Quest acquisition histogram of B16F10 cell cycle 
phases after 48 h irradiation. Red dot refers to control 
group; green line refers to 150 J/cm2 group and purple curve 
refers to 1050 J/cm2 group.
Cell-Quest acquisition histogram of B16F10 cell cycle phases after 72 h irradiat onFigure 5
Cell-Quest acquisition histogram of B16F10 cell cycle 
phases after 72 h irradiation. Red dot refers to control 
group; green line refers to 150 J/cm2 group and purple curve 
refers to 1050 J/cm2 group.
Graphic showing B16F10 cell death percentage after 72 h of laser irradiatioFigure 6
Graphic showing B16F10 cell death percentage after 
72 h of laser irradiation. Statistically significant difference 
is indicated by asterisk (*P < 0,05).
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to the control group. The connective tissue of the capsule
had fewer immune cells in a greater area of thin fibers of
collagen (Figure 11).
Histological sections of the 1050 J/cm2 group showed
remarkably atypical melanoma cells. Nuclei were of vari-
ous sizes and shapes, and apoptotic figures and the fre-
quency of mitotic cells were high. Necrotic areas were
more common and extensive compared to the other
groups. Immune cells were observed in greater numbers
in the tumor mass and in the highly vascular capsule (Fig-
ure 12).
Discussion
In the present paper we have investigated the effects of
LLLT on malignant melanoma, in vitro and in vivo. The
question of a potential unwanted proliferative effect of
low-level laser irradiation, has been raised by some
authors [15,16]. We observed that laser irradiation with a
low LLLT dose of 150 J/cm2 presented opposite effects
when applied to each distinct situation. In the cultured
melanoma cells, we found that the two LLLT doses pre-
sented a non-significant effect on tumor cells or even an
inhibitory effect of cancer cell proliferation through
increased apoptosis. In the in vivo experiment the low
dose (150 J/cm2) was not inducing any changes in the
cancer cell behavior. However, the high dose (1050 J/cm2)
showed a significant increase in tumor mass volume and
Graphic showing melanoma tumor growth in the three groups until the 10th day after irradiationFig re 7
Graphic showing melanoma tumor growth in the 
three groups until the 10th day after irradiation.
Graphic showing the percentage of volume growth on the 10th day after rradiation of the three groupsFigure 8
Graphic showing the percentage of volume growth 
on the 10th day after irradiation of the three groups. * 
= p < 0.05 when compared to the control group indicated by 
One Way ANOVA and Bonferroni's Multiple Comparison 
Test (*P < 0,05).
photography showing the macroscopic appearance of the tumorFigure 9
photography showing the macroscopic appearance of 
the tumor. A - control group, B - 150 J/Cm2 group and C - 
1050 J/Cm2 group.
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considerable histological alterations which indicate a
worsening of the cancer. The results have several implica-
tions for research and clinical practice.
Cell culture is an important method for studying basic
biological processes and to understand the possible cell
reactions to treatments. Many kinds of tumor cell lines
have been studied, ranging from carcinomas to sarcomas
and myelomas [3,4,6,8,10,17]. We chose B16F10
melanoma cell line because it's a pigmented, highly
aggressive and invasive tumor [18]. Our results of non-sig-
nificant LLLT effects in the in vitro tests of cell viability are
in accordance with the largely non-significant findings of
other authors [9].
Our cell cycle analysis with flow cytometry method indi-
cated a significant increase in cell death in 72 h of the
1050 J/cm2 group. Some authors have previously found
increased cell death in vitro after LLLT irradiation. LLLT
fluences higher than 6 J/cm2 seemed to increase cell death
in melanoma cell lines (G361, LD50 and SKmel-23), and
especially in melanin producing cells [19]. There seems to
be an inverse relationship between laser fluence and
melanoma cell growth in culture [11]. Other authors have
reported an increase in G0/G1 phase of the cell cycle using
HTB66 melanoma cell line [2], but our results did not
support this finding. One important aspect of our findings
is the discrepancy between the in vitro and in vivo experi-
ments. It seems necessary to be careful in generalizing in
vitro results, as cell-matrix interactions and cell behavior
in the complex environment of tissues may produce unex-
pected reactions.
Our results demonstrated a significant tumor growth
when the animals were irradiated with the high dose of
Hematoxylin-eosin stained photomicrograph showing tumor mass (A), necr tic area (B) in the 1050 J/Cm2Figure 12
Hematoxylin-eosin stained photomicrograph show-
ing tumor mass (A), necrotic area (B) in the 1050 J/
Cm2. ×400.
Hematoxylin-eosin stained photomicrograph showing (A), connective tissue tumor ca sule (B) tumor mass in the 150 J/Cm2Figure 11
Hematoxylin-eosin stained photomicrograph show-
ing (A), connective tissue tumor capsule (B) tumor 
mass in the 150 J/Cm2. ×400.
Hematoxylin-eosin stained photomicrograph showing tumor cells (A), co nective tissue tumor capsule (B) Tumor mass inth  control groupFigure 10
Hematoxylin-eosin stained photomicrograph show-
ing tumor cells (A), connective tissue tumor capsule 
(B) Tumor mass in the control group. ×400.
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1050 J/cm2. This finding is in line with observations of
enhanced Ehrlich ascites tumor growth after laser irradia-
tion which have been reported in an early paper on LLLT
[12]. However it seems that typical LLLT doses ranging
from 1 - 4 Joules have no influence on tumor growth, or
rather they can inhibit it in implanted glioma in mice
[13].
Histological data also revealed that important differences
in cell morphology were induced by high doses of laser
irradiation. The immune cells (lymphocytes, plasma cells
and macrophages) increased in the group irradiated with
the high dose of 1050 J/cm2. This group also presented
significant areas of necrosis, a high number of atypical
cells and an increase in the number of blood vessels.
Zhu et al. [8] reported differences in Focal Adhesion
Kinases (FAK) and van Leeuwen et al. [7], showed differ-
ences in α-1 and β-4 subunits of integrin molecule. Both
factors are important in tumor genesis and metastasis.
Many factors may contribute to tumor growth and most of
them can be modulated by laser irradiation, for instance:
low-level laser can enhance angiogenesis [20-22], growth
factor synthesis [23-25], inflammatory metabolites [26] as
well as modulate immunological cells and inflammation
[27-29].
Conclusion
LLLT administered by a dose of 150 J/cm2 appears safe
with only minor effects on B16F10 melanoma cells prolif-
eration in vitro and no significant effect on tumor growth
in vivo. However, a high irradiance (2.5 W/cm2) combined
with high dose of 1050 J/cm2, can stimulate melanoma
tumor growth with distinct histological features in vivo.
Further studies are necessary to elucidate the main factors
that are responsible for the different behaviors on tumor
cells in response to laser light, and to determine laser irra-
diance and energy thresholds for stimulation of abnormal
melanoma cell behavior.
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